Table 8.

SES differences in choice of providers for the treatment of malaria

	Inyi	Udi	Oji	Nachi
	n (%)	n (%)	n (%)	n (%)
Home treatment
Q1: most poor	0 (0)	2 (25.0)	4 (80.0)	2 (33.3)
Q2:average	6 (50.0)	6 (75.0)	0 (0)	2 (33.3)
Q3: least poor	6 (50.0)	0 (0)	1 (20.0)	2 (33.3)
Chi square (p-value)	6.3 (0.04)	6.4 (0.04)	4.6 (0.10)	2.1 (0.7)
Concentration index	0.34	-0.84	-	0.01
Traditional medicines
Q1: most poor	8 (32.0)	3 (100.0)	6 (75.0)	10 (31.3)
Q2:average	9 (36.0)	0 (0)	1 (12.5)	6 (18.7)
Q3: least poor	8 (32.0)	0 (0)	1 (12.5)	16 (50.0)
Chi square (p-value)	0.05 (0.9)	10.1 (0.01)	5.3 (0.07)	5.1 (0.08)
Concentration index	-0.08	-	-	0.13
Private hospital
Q1: most poor	14 (44.8)	2 (12.5)	6 (46.1)	3 (16.7)
Q2:average	6 (18.7)	4 (25.0)	5 (38.5)	6 (33.3)
Q3: least poor	12 (37.5)	10(62.5)	2 (15.4)	9 (50.0)
Chi square (p-value)	4.2 (0.1)	4.8 (0.09)	1.05 (0.6)	3.0 (0.2)
Concentration index	-0.04	0.33	-0.19	0.23
Public hospital
Q1: most poor	2 (14.3)	5 (31.3)	1 (25.0)	1 (33.3)
Q2:average	7 (50.0)	8 (50.0)	2 (50.0)	1 (33.3)
Q3: least poor	5 (35.7)	3 (18.7)	1 (25.0)	1 (33.3)
Chi square (p-value)	2.8 (0.3)	3.1 (0.2)	.39 (.82)	0.01 (0.9)
Concentration index	0.15	0.12	-	-
Patent medicine dealer
Q1: most poor	33 (36.7)	9 (25.7)	13 (35.1)	21 (41.1)
Q2:average	30 (33.3)	12 (34.3)	11 (29.8)	19 (37.3)
Q3: least poor	27 (30.0)	14 (40.0)	13 (35.1)	11 (21.6)
Chi square (p-value)	1.1 (0.6)	0.4 (0.8)	4.1 (0.39)	7.7 (0.02)
Concentration index	-0.05	0.10	0.01	-0.11
Primary Healthcare (PHC) centre
Q1: most poor	0 (0)	0 (0)	0 (0)	0 (0)
Q2:average	1 (33.3)	0 (0)	1 (100)	1 (100)
Q3: least poor	2 (66.3)	1 (100)	0 (0)	0 (0)
Chi square (p-value)	2.1 (0.4)	1.6 (0.4)	1.6 (0.5)	2.2 (0.3)
Concentration index	-	-	-	-